U.S. PRE-MARKET MOVERS: AEGR ASNA CPXX FMI LORL MWIV NPSP SNDK

Equity movers in early trading, with shrs traded pre-mkt:

Advancers:

  • FMI +131.5% (522.7k); Sells Majority Stake to Roche
  • CPXX +28.2% (134k); CPX-351 Data
  • EYES +14.1% (24k); Argus II System Gets Health Canada Ok
  • AGEN +11.5% (682.7k)
  • ARTX +8.4% (2k); Unit Gets $17m in New Orders
  • AEGR +8.4% (1.2k); Sees 2015 Juxtapid Sales $195m-$215m, Est. $229.3m
  • NPSP +8.4% (9967.9k); Shire to Buy NPS Pharma for $46-Shr Cash
  • MWIV +8.2% (6.3k); AmerisourceBergen to Buy MWI for $190/Shr
  • LULU +6.2% (93.7k); Boosts 4Q EPS Forecast Above Est.; Upgraded at Sterne Agee
  • BMY +6.5% (295.9k); Checkmate -017 Stopped Early
  • XON +6.3% (1.7k)
  • CNAT +5% (9.1k)
  • MSTX +4.8% (14.8k)
  • EXPR +4.5% (15.2k); Raises 4Q, Full Year EPS, Comp Sales Views
  • EOPN +3.7% (1.7k)
  • SGEN +4.1% (17.9k); Seattle Genetics, Bristol-Myers Exploring Adcetris, Opdivo Combo
  • BLCM +3.7% (4.1k); New Buy at Jefferies; New Overweight at Piper
  • JUNO +2.6% (13.5k)
  • AWAY +3.2% (1.5k); Upgraded at Macquarie
  • AFFX +3% (2.4k); 4Q Rev. $93m, Est. $89.9m
  • WIN +2.8% (3.2k); Upgraded at BofA
Decliners:
  • ARWR -22.6% (217.3k); FDA Informed Co. of Partial Clinical Hold
  • ECR -8.4% (1.1k); Downgraded at Goldman
  • TIF -8% (29.7k); Sees Yr Adj. EPS $4.15-$4.20, Saw $4.20- $4.30, Est. $4.32
  • SNDK -8.3% (311.7k); Prelim 4Q Rev. Misses Forecast, Est.
  • ASNA -6.9% (10.2k); Cuts Full Year Fiscal ’15 EPS View
  • SN -6.6% (9.3k)
  • SRPT -4.2% (43.6k); Decline in Walking Seen on Eteplirsen at 168 Wks
  • LORL -3.6% (4.7k); Loral, Ontario Teachers’ Talks Said to Have Ended: NY Post
  • SWN -2.5% (25.2k); To Sell 20.3m Shrs; 4Q Prelim. Production Rises Y/y
May Move:
  • AA: Upgraded at Nomura
  • AAL: Prelim. 4Q Prasm Below Forecast
  • AAPL: Apple’s IPhone 6, IPhone 6 Plus ‘in Stock’ Online: Digital Trends
  • ABBV: Says FDA Approves Duopa for Parkinson’s Disease
  • ABC: AmerisourceBergen to Buy MWI for $190/Shr
  • ACOR: 2015 Ampyra Sales View Tops Est.
  • ADC: Files $500m Mixed Securities Shelf
  • ADMS: Sees Completing Enrollment in ‘EASE LID’ Mid-’15
  • ADT: Downgraded at Morgan Stanley
  • AIV: Upgraded at Wells Fargo
  • AL: Air Lease Delivering 8 Boeing 777-300er in 2015 to 6 Airlines
  • ALJ: Upgraded at Goldman
  • ALK: Upgraded at Evercore ISI
  • ALLY: GM to Use Financial Lending Unit for Subsidized Leases: WSJ
  • ALNY: ALN-AT3 Has Antithrombin Knockdown Up to 70% in Study
  • ALQA: New Outperform at Northland
  • ALR: Sees Using $127m Proceeds From Optum Deal to Pay Debt
  • AMAG: Sees FDA Decision on Makena Single-Dose Vial in 2Q; Sees 4Q ‘14 Pro Forma Product Sales $74m
  • ANAC: No AN2728 Related Malignancies Identified in Studies
  • AOL: Downgraded at Cowen
  • APA: May Delay Sale of Remaining WA Assets, Australian Says
  • ARAY: New Outperform at Northland
  • ARUN: Downgraded at JMP Securities
  • ASFI: May Be Delisted by NASDAQ
  • ASPX: Says Topline Results Favorable From SD-809 Trial (Yday)
  • ATVI: Activision, Tencent Say Call of Duty Online Live in China
  • AVB: Upgraded at Jefferies
  • AVEO: Holder Baupost Reports Zero Passive Stake
  • BA: Air Lease Delivering 8 Boeing 777-300er in 2015 to 6 Airlines
  • BABY: Sees 2015 Adj. EPS $1.40-$1.44, Est. $1.43; Sees 1Q Adj. EPS 28c-30c, Est. 29c
  • BAC: Cuts Size of Bonus Pool Money, WSJ Reports
  • BAS: Dec. Well Servicing Rig Utilization Rate Falls M/m
  • BBG: Downgraded at Goldman
  • BBW: 4Q Prelim Rev. $130m, Est. $113.3m
  • BIIB: To Buy Pain Drug Co. Convergence for Up to $675m
  • BNCL: Depositors Approved Plan of Conversion
  • BODY: To Shut 265 Stores, Terminate 2,500 Workers: WSJ
  • BURL: Boosts 4Q Adj. EPS View Above Est.; CFO Resigned
  • BX: Blackstone’s Bill Mulrow Appointed Cuomo’s Top Aide
  • C: Appoints Gonzalo Luchetti as Retail Bank Head for Asia
  • CARB: Board Rejects J2 Offer; Adopts A Stockholder Rights Plan
  • CBK: Raises Low End of FY4Q Rev. Outlook
  • CBS: Upgraded at Cowen
  • CCL: Upgraded at Natixis
  • CHEF: To Buy Del Monte Meat for $191.2m Cash/Stock/Notes
  • CHH: Plans 15 New Sites in France for 201
  • CHK: Upgraded at Goldman
  • CHRW: Upgraded at Barclays
  • CHTR: New Outperform at Wells Fargo
  • CLUB: 4Q Prelim. Rev. at Higher End $108m-$109m, Est. $108.3m
  • CMFN: Files $500m Mixed Securities Shelf
  • COH: Ex-Coach Chairman Frankfort Joins Sycamore Partners: NYP Link
  • CPRX: Sees Completing Firdapse LEMS NDA Filing in 3Q
  • CPST: Downgraded at Roth Capital
  • CTXS: Buys Sanbolic, No Terms
  • CYNO: Rated New Outperform at Northland, PT $39
  • CZR: Appaloosa Files Involuntary Bankruptcy Petition Against Caesars
  • DHI: Upgraded at Keybanc, Raymond James; Downgraded at JPMorgan
  • DLR: Downgraded at Jefferies
  • DLTR: Expects Pact With FTC Staff by End of Jan.
  • DNKN: 2015 EPS View Misses Est.
  • DOV: Reports New 15m-Shr Buyback Authorization
  • DPM: Downgraded at Goldman
  • DRII: Upgraded at Goldman
  • DRL: Got FDIC Letter That Restoration Plan Didnt Meet Criteria
  • DWRE: To Acquire Tomax for $60m Cash, $15m Other Payments
  • DYN: Upgraded at Tudor Pickering
  • EBS: Prelim 2014 Adj. Net $53m to $55m
  • EMC: Expands Board; Says Elliott Agreed to Vote in Favor of Slate
  • EVTC: Downgraded at BofA
  • EXC: Upgraded at Tudor Pickering
  • EXK: Says 4Q Gold Production Down 14%
  • F: Testing Car Sharing Service in London: Times
  • F: To Invest $1b to Build Manuf. Unit in Gujarat: CNBC-TV18
  • FCEL: Files $200m Mixed Securities Shelf; Registers 14.6m Shrs for Holder
  • FCFS: Upgraded at Janney Montgomery
  • FMC: Upgraded at BofA
  • FOLD: Provides FY ’15 Strategic Outlook; Migalastat Monotherapy MAA Submission on Track Mid-2015
  • FTR: Upgraded at BofA
  • GCAP: Dec. Avg Daily Retail OTC Trading Vol. Down 2.9%
  • GCO: Still Sees Yr Adj. EPS $4.75-$4.85, Est. $4.81; QTD Comp Sales Rose 10%
  • GM: To Use Financial Lending Unit for Subsidized Leases: WSJ
  • GMAN: Sees 4Q EPS 5c-8c, Saw 3c-8c
  • GME: To Use Microsoft Azure to Stream Video Game Content
  • GOOG: Downgraded at Atlantic Equities
  • GOV: Downgraded at Jefferies
  • GS: Ireland Picks Goldman Sachs to Advise on AIB; Goldman Sachs May Be Acting ‘Pro Bono’ on AIB, Minister Says; Downgraded at JMP Securities
  • GSAT: FCC Engineers Group Filing Looks ‘Very Positive’ for GSAT: Odeon
  • HCA: Prelim. ‘14 Adj. Ebitda Above Prior View
  • HPQ: Files Suits in Five Countries Related to Inkjet Cartridges
  • HUBG: Downgraded at Barclays
  • ICPT: Still Sees Starting Nash Phase 3 Study in 1H 2015 0
  • IKAN: Registers 16.9m Shares for Sale
  • IMGN: To Discuss ’15 Product Pipeline at JPM Conference
  • IMPR: 4Q Prelim Rev. Above $26m-$27m, Est. $26.6m
  • INFI: 2015 Rev. Forecast Tops Est.; Sees 3 Clinical Studies of Duvelisib Starting in Yr
  • INSY: To Initiate Five Phase III Clinical Trials
  • INTC: Intel Capital, LB Investment Invest $15m in LeWa, Maeil Reports
  • IR: Upgraded at Morgan Stanley
  • IRMD: Sees 4Q Rev. About $3.5m, Saw $3.0m
  • ISSI: Prelim 1Q Rev $80.5m-$81m,Saw Rev. $80m-$85.0m, Est. $82.6m
  • IWSY: Files $12m Mixed Securities Shelf
  • JCP: Sees Pretax Charges About $21m in 4Q
  • JOY: Downgraded at RBC Capital
  • K: To Buy Majority Stake in Bisco Misr
  • KBH: Upgraded at Raymond James
  • KERX: Reports Transition of Leadership
  • KKD: FY2016 Adj. EPS View Trails Est.; Reaffirms FY2015
  • KND: Holder Point72 Reports 8.2% Passive Stake
  • KNX: Upped to Overweight at Barclays
  • KO: Marketing Executive Leaves to Advise Hillary Clinton: WSJ
  • LC: New Underperform at Sterne Agee
  • LH: Upgraded at Robert Baird
  • LNG: Holder Baupost Reports 10.1% Passive Stake
  • LOCM: Prelim 4Q Rev. $16m-$16.5m, Saw $20m-$23m , Est. $21.6m
  • MAA: Upgraded at Jefferies
  • MDC: Downgraded at Keybanc; Upgraded at Raymond James
  • MIK: Files Prospectus on Behalf of Selling Holders
  • MNKD: CEO Alfred Mann to Be Exec Chairman; Edstrom Named CEO
  • MR: 2014 Prelim. Net Rev. $ 1.32b, Est. $1.33b
  • MRK: Sees Hepatitis C Combo NDA Submission in 1H
  • MS: Downgraded at JMP Securities
  • MTBC: 4Q Rev. Trails Two Ests
  • MWE: Downgraded at Goldman
  • NFLX: Dec. Verizon Fios ISP Speed 3.36 Mbps
  • NHTB: Files $50m Mixed Securities Shelf
  • NLS: 4Q Prelim Rev., Profit Cont Ops/Shr Top Ests.
  • NML: Affiliate Fund Said Near Deal to Acquire Italy’s Bruno Magli: NYT
  • NVS: Forms JV With Qualcomm to Invest in Early-Stage Cos.
  • NWY: Sees 4Q Adj. Oper. Break-Even to Slight Loss,Est. Break-Even
  • OFIX: Prelim 2014 Sales $397m-$401m, Est. $406.0m (2 Ests.)
  • OII: Off Goldman Conviction Buy List, Stays Buy
  • ONDK: New Buy at Jefferies, Needham, Stifel
  • PAYC: Holders to Sell 5.6m Shrs
  • PCAR: Upgraded at RBC Capital
  • PE: Upgraded at Goldman
  • PETM: Holder Jana Partners Sold Shares in Last 60 Days
  • QCOM: China to Announce Qualcomm Probe Result When Beneficial: QQ.com
  • QDEL: Sees 4Q Revenue $63m-$64m; Est. $57.8m
  • QGEN: Full Yr EPS Guidance Cut to ~$1/Shr on $47m Charges
  • RCL: Downgraded at Natixis
  • RDUS: Has Positive Abaloparatide-SC Phase 3 Top-Line Results
  • RMP: New Buy at Goldman, New Outperform at BMO, RBC
  • RPAI: Buys Retail Portion of Site for $162.8m
  • RTRX: Buys Right to Buy Cholic Acid From Asklepion Pharma
  • RUSHA: Upgraded at BB&T
  • RVNC: Cuts 2014 Adj. Oper. Expense Forecast
  • RYL: Upgraded at Raymond James
  • SEM: Sees 2015 EPS Below Ests.; Downgraded at JMP Securities
  • SF: To Buy 10% Shrs Offered in Sidoti’s Proposed IPO
  • SGGH: Reports Sale of Nabco for $78m
  • SHW: Downgraded at UBS
  • SLB: Downgraded at Goldman
  • SLG: Upgraded at Jefferies
  • SLH: Upgraded at Goldman
  • SPF: Upgraded at JPMorgan; Raymond James
  • SSH: To Meet With FDA on Jan. 15 on Implantable System
  • STE: Steris, Synergy Get Second Request From FTC
  • TER: Downgraded at Credit Suisse
  • TOL: Downgraded at Keybanc
  • TRIV: Sees ’15 Rev. $45m-$49m, Est. $48.4m
  • TRNX: 4Q Prelim Rev. $92.8m, Est. $87.3m
  • TSL: Connects 90 Mw of Solar Power to Chinese Grid
  • TSO: Carson Refinery Reports Breakdown, Flares Gases
  • TSRO: Says U.S. FDA Pdufa Action Date Oral Rolapitant Sept. 4,
  • TW: Downgraded at Goldman
  • TWTR: May Sell Ads on Other Publishers’ Apps, Websites: WSJ
  • UAL: Prelim. 4Q Mainline Traffic Up 0.2%
  • UIHC: Files $50m Mixed Securities Shelf
  • UPL: 2015 Natgas Swaps at Wtd Avg. $4/Mcf
  • VAC: Downgraded at Goldman
  • VRTX: Prelim. 4Q Kalydeco Rev. $120m, Est. $122.2m
  • VTL: Vti-208 Phase 3 Trial Remains on Track for Data in 2Q
  • W: Thanksgiving-Cyber Monday Gross Sales up 51%
  • WMGI: Prelim 4Q Rev. $83.3m, Est. $84.0m
  • WNR: Downgraded at Goldman
  • WR: Downgraded at JPMorgan
  • ZFGN: Registers to Sell 2.5m Shrs
  • ZGNX: Zohydro ER Had 19,000 Prescriptions in 4Q, Up 26% Q/q
  • ZINC: Upgraded at CJS Securities

To continue reading this article you must be a Bloomberg Professional Service Subscriber.